Syneos Health is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. Operating across more than 110 countries, we bring together a talented team of over 26,000 professionals with a deep understanding of patient and physician behaviors and market dynamics. We are the only fully integrated organization combining Contract Research Organization (CRO) and Contract Commercial Organization (CCO) capabilities. This unique positioning enables us to synchronize clinical development and commercial execution, helping clients streamline product development, reduce time to market, and maximize patient impact. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers' delivery of important therapies to patients.

When we partner, your goals become our goals. We listen and bring specialized experts together when and where you need them to support your teams and immediately add value, increasing confidence at each step on your journey. Our commitment to the success of our customers starts with how we craft individual project teams. Each team includes specialized experts suited to meet your unique needs, delivering deep insights to accelerate your therapies to market. We're inspired by what's possible. We take the time to truly understand what drives your program and makes it unique. Then we bring the right therapeutic, scientific and operational experts to the table to work with yours.

We provide comprehensive solutions spanning the entire clinical-to-commercial spectrum. Our Clinical Development services offer expertise and innovation from Early Phase to Late Phase trials, including decentralized solutions, study start-up, clinical operations, safety/pharmacovigilance, and regulatory services. Our Medical Affairs capabilities deliver strategic insight, scientific expertise, organizational excellence and purposeful engagement across the product lifecycle. Our Commercial Delivery solutions range from Deployment Solutions and Communications to our integrated Full-Service Commercial offering, powered by our AI-driven Kinetic platform. We also provide specialized Consulting services across portfolio strategy, brand commercialization, medical affairs, quality and compliance, risk and program management, pricing, market access and HEOR, and research and development.

Our Vision is to shorten the distance from lab to life. We're motivated by the promise of science to positively impact the health of our communities. To us, a patient isn't a number; they are a family member, they are a colleague, and they are our neighbors. Each life we positively impact makes our work worthwhile. We hold ourselves accountable to leverage our diverse backgrounds, perspectives and experiences as we partner side-by-side with our customers to accelerate the delivery of important therapies to patients worldwide.

We are committed to collaboration. Each day we have the opportunity to call upon some of the industry's most dynamic, thought-provoking colleagues. Together, we are committed to our customers' success. We work across our company, and across our disciplines, sharing ideas, respecting one another's opinions and providing constructive feedback. It's this dynamic that makes Syneos Health different. We know that collaboration with our colleagues and with our customers unlocks creativity, innovation and new solutions. We support a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

We offer three key differentiators: First, we are a Partner with Purpose - when we partner, your goals become our goals, and we bring specialized experts together to support your teams and add value at each step. Second, we provide unmatched Therapeutic Depth - our commitment starts with how we craft individual project teams, with specialized experts delivering deep insights to accelerate your therapies to market. Third, we deliver AI-Driven Performance - our AI-powered innovations enhance performance across your enterprise, connecting and harmonizing data to deliver precise, actionable insights. We help you move faster, adapt with agility and execute more effectively at scale. In the last five years, we have helped develop or commercialize 93% of novel drugs approved by the FDA, including 96% of oncology drugs, 89% of CNS drugs, and 92% of general medicine drugs.

Our Impact Strategic Framework demonstrates how we act responsibly and sustainably to enable our customers to improve the health of patients. It is aligned with our Vision and Values and includes four pillars: Advancing Health, Caring for People, Operating Responsibly and Protecting the Planet. We leverage our expertise to deliver solutions that improve patients' lives—including clinical trial safety and quality, ethics in research and development, and access and affordability. We have joined The Climate Pledge with the intent of reaching net zero carbon emissions by 2040. We maintain a 29% sustainable property footprint across our office properties and have advanced our decarbonization strategy with plans for Science Based Targets initiative validation. Environmental, Social and Governance principles are embedded in our work practices, influencing the way we support our customers deliver life-changing therapies.

While we all can make a positive difference in the world as individuals, it is when communities act together that we can make the greatest impact. We believe that through our efforts as a global Syneos Health community – by acting responsibly and sustainably – we can help advance health and change patients' lives. This belief is the foundation for our Impact Strategy. From clinical development through commercialization, Syneos Health supports the development of new and innovative therapies and enhances patients' access to them. We are committed to helping improve the environment and doing our part to leave the planet better than we found it.

We believe that by diversifying and strengthening our knowledge of real-world challenges, we will create better outcomes for patients worldwide. Our goal is to become the partner of choice in driving clinical trial diversity by leveraging data and providing insights to achieve better health outcomes for all patients. We support inclusivity at all levels including the Syneos Health DE&I Council, our Employee Resource Groups (ERGs) and our business leader and reverse mentoring programs to promote diverse thinking and provide leadership opportunities for employees at all levels. Our ERGs are voluntary, employee-led, and Company-supported, aiming to build community and solve business problems while cultivating leadership skills. We integrate DE&I into our processes, organizational structure, and clinical development project planning and execution. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.